Allergan — Drug Prices & Medicare Spending

Allergan manufactures 11 drugs tracked by Medicare Part D with total spending of $2.0B.

Drugs Tracked

$2.0B

Medicare Spending

$53.48

Avg Cost/Claim

100%

Have Generics

Allergan Drugs — Ranked by Medicare Spending

#	Drug	Generic Name	Cost/Claim	Medicare Spending	YoY Change	Generic?
1	Restasis	Cyclosporine (ophthalmic)	$184.00	$456.0M	-24.6%	Yes
2	Lumigan	Bimatoprost	$94.00	$234.0M	-18.4%	Yes
3	Durysta	Bimatoprost (implant)	$944.00	$234.0M	+28.4%	Yes
4	Saphris	Asenapine	$285.00	$178.0M	-18.4%	Yes
5	Namzaric	Donepezil/Memantine	$285.00	$178.0M	-14.6%	Yes
6	Namenda	Memantine	$22.00	$145.0M	-38.6%	Yes
7	Escitalopram	Escitalopram Oxalate	$10.00	$123.0M	-32.4%	Yes
8	Memantine	Memantine Hydrochloride	$19.00	$123.0M	-24.6%	Yes
9	Bimatoprost	Bimatoprost	$66.00	$123.0M	-14.6%	Yes
10	Savella	Milnacipran	$142.00	$123.0M	-8.4%	Yes
11	Risedronate	Risedronate Sodium	$27.00	$67.0M	-22.4%	Yes

Allergan manufactures 11 drugs tracked by Medicare Part D, with total annual spending of $2.0B.

Durysta (Bimatoprost (implant)) is the most expensive at $944.00 per claim.

11 of 11 Allergan drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.